Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America
Recruiting · NCT07262320
Conditions: Dialysis, Critically Ill Acute Kidney Injury, Renal Replacement Therapy for Acute Kidney Injury in ICU, Acute Kidney Injury, Renal Replacement Therapy, AKI
At a glance
- Research payments reported, 2025
- $40,000
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 1,000
About the trial
- Sponsor
- University of Alabama at Birmingham (with Vantive Health LLC)
- Dates
- Started 2026-03-01; completion 2027-06-30
- Results posted
- Not yet
This is an international, multicenter, observational study aimed at investigating acute kidney injury requiring renal replacement therapy (AKI-RRT) in Latin American countries. The main questions this study aims to answer are: * What is the epidemiology, outcomes, and processes of care for patients with AKI-RRT in Latin America? * How do outcomes differ across different countries in Latin America? * What factors (demographics, clinical, socioeconomic) influence outcomes in patients with AKI-RRT in Latin America? The main aims of this study are to: * Establish a comprehensive database containing clinical, laboratory, treatment, process, and outcome data of patients with AKI-RRT in Latin Am…
From ClinicalTrials.gov, last updated 2026-03-12. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Vantive US Healthcare LLC reported $40,000 in research payments for this study in 2025 (1 payments).
Products named: Renal - Crrt
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.